Target intelligence / Profile preview

Coastal Taipan venom toxins (OSVT)

Target
OSVT
Molecular classification
Phospholipase A2, Prothrombin activator, Three-finger toxin, Kunitz-type protease inhibitor
01

Overview

The venom toxins of Oxyuranus scutellatus, commonly known as the Coastal Taipan, represent a complex mixture of highly potent bioactive proteins and peptides [PMID: 22403543]. The most significant components include taipoxin, a trimeric presynaptic neurotoxin that disrupts neurotransmitter release at the neuromuscular junction, and a prothrombin activator known as oscutarin C that triggers massive systemic coagulation [UniProt: P00626, P81162]. These toxins collectively cause rapid-onset paralysis, respiratory failure, and venom-induced consumption coagulopathy in bite victims [PMID: 15451024]. While these toxins are lethal, they serve as the specific targets for therapeutic antivenoms, which utilize polyclonal antibodies to neutralize the venom's enzymatic and binding activities [WHO Guidelines]. Additionally, individual components like the prothrombin activators have been studied for their potential applications in diagnostic hematology and as templates for novel anticoagulant drugs [T3DB]. The venom also contains phospholipase A2 enzymes and three-finger toxins that contribute to local tissue damage and systemic toxicity. Effective management of envenomation requires rapid administration of specific antivenom to prevent irreversible binding of neurotoxins to their physiological targets.

Other names
Oxyuranus scutellatus venomCoastal Taipan venomTaipoxin complexOscutarin CCoastal Taipan prothrombin activatorScutellatus prothrombin activator
02

Mechanism of action

Neutralization of venom components via antibody binding to prevent interaction with physiological substrates and receptors.

03

Biological functions

NeurotoxicityCoagulationProteolysisPhospholipid hydrolysisInhibition of acetylcholine release
04

Disease associations

Snakebite envenomationVenom-induced consumption coagulopathy (VICC)Neurotoxic paralysisMyolysisRespiratory failure
05

Safety considerations

AnaphylaxisSerum sicknessRapid clinical deteriorationAntivenom-induced hypersensitivity
06

Interacting drugs

Taipan Antivenom

1 more in the full profile.

07

Biomarkers

Prothrombin time (PT)International Normalized Ratio (INR)Fibrinogen levelCreatine kinase (CK)Venom-specific ELISA

Beyond the preview

Go deeper on Coastal Taipan venom toxins (OSVT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coastal Taipan venom toxins (OSVT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call